Nasal Drug Delivery Technology Market Report 2017 -2025: By product,By geography and company profile

Nasal drug delivery technology is the administration of drug through the nasal route. Nasal route of administration provides direct access to the systemic circulation. The nasal cavity is an easily accessible route which is generally well tolerated. Drugs administered through the nasal route are available in different dosage forms, such as liquid drops, liquid spray, Aerosol, suspension spray, gel etc. Nasal drug delivery offers several advantages, such as a large surface area for drug absorption, convenience, and good patient compliance, rapid attainment of therapeutic drug levels in the blood, and potential of direct drug delivery to the brain along the olfactory nerves etc. In nasal drug delivery, drugs are given in multi dose as well as single dose. Intranasal medication administration offers a needleless solution to drug delivery. Many drugs have been shown to achieve better systemic bioavailability through the nasal route than by oral administration. Different formulations are delivered through the nasal route, such as drugs, viscosifying agents, solubilizes, surfactants, bioadhesive polymers, preservatives etc.

Report Overview and TOC @ https://www.transparencymarketresearch.com/nasal-drug-delivery-technology-market.html

Factors such as growing preference for nasal drug delivery, technological advancement, growing adoption for self-administration, and growing incidence of chronic diseases are likely to drive the global nasal drug delivery technology market. New product innovation, large pipeline products, and merger & acquisition activities are other factors which will accelerate the nasal drug delivery technology market globally. On the other hand, complications related to nasal drug delivery, such as risk of local side effects and low bioavailability are factors which may hinder the growth of the nasal drug delivery technology market.

The nasal drug delivery technology market has been segmented by product type, application, end users, and geography. In terms of product type, the market is classified into liquid devices and powder devices. Liquid devices is further classified into vapor inhaler, mechanical spray pumps, gas driven spray systems, and electrically powered nebulizer and droppers. Powder devices are further classified into mechanical powder spray and breath actuated inhalers. In terms of application, the market is classified into nasal vaccination, diagnostic drug delivery, delivery of drugs to brain through nasal cavity, and delivery of peptide and non-peptide drugs. In terms of end users, the market is classified into hospital, specialty clinics, vaccination centers, and ambulatory surgery centers.

Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30338

Geographically, the nasal drug delivery technology market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

North America dominates the nasal drug delivery technology market due to advanced technology, new product innovation, growing prevalence of chronic obstructive pulmonary disease, and increasing adoption of early treatment procedures. Chronic obstructive pulmonary disease is the third leading cause of death in the United States. According to American Lung Association more than 11 million people have been diagnosed with chronic obstructive pulmonary disease. Europe is the second largest market for nasal drug delivery technology due to increasing research & development activities and growing consumption of tobacco.

For Specific and Customized requirements @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=30338

According to World Health Organization Europe has the highest prevalence of tobacco smoking among adults (28%) and some of the highest prevalence of tobacco use by adolescents. The market in the Asia Pacific region is expected to expand at a higher rate due to increasing investment in research & development activities, growing prevalence of chronic diseases, and growing awareness among people.

Major players operating in this market include Becton, Dickinson and Company, OptiNose US Inc., Bespak Europe Ltd, Kurve Technology, Inc., AstraZeneca Plc, Teleflex Medical Europe Ltd., AptarGroup, Inc., Procter & Gamble, GlaxoSmithKline plc, and Janssen Global Services, LLC.

Pre Book full report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=30338<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.